Assessing Modified CBTi in Adults with Insomnia Disorder
Launched by IDAHO STATE UNIVERSITY · Sep 16, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a modified version of Cognitive Behavioral Therapy for Insomnia (CBTi), a recommended treatment for people struggling with insomnia. The goal is to see if these changes can make the therapy more accessible and effective for individuals looking to improve their sleep and cognitive health. Insomnia can lead to various health issues, including memory problems and a higher risk of conditions like Alzheimer's disease. By focusing on treating insomnia, researchers hope to improve overall cognitive functioning and reduce the risks associated with cognitive decline.
To participate in the trial, individuals need to be at least 18 years old and actively seeking help for their sleep issues. They should be stable on any non-sedating medications for at least a month. The trial is open to everyone, regardless of gender, but those with certain conditions, like severe brain damage or untreated sleep disorders, will be excluded. Participants can expect to attend weekly therapy sessions, either in-person or online, where they will learn techniques to improve their sleep. This trial aims not only to help those suffering from insomnia but also to enhance our understanding of how effective treatments can be tailored to individual needs.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • At least 18 years of age;
- • Seeking treatment for an insomnia complaint, assessed by self-report;
- • Stable on any prescribed, non-sedating medications (≥ 1 month), assessed by self-report and structured clinical interview
- Exclusion Criteria:
- • Inability to speak and read English;
- • Moderate to severe brain damage, assessed by the MoCA;
- • Inability to attend weekly therapy sessions either in-person or via telehealth;
- • Pregnancy, assessed by self-report, because sleep disturbances due to pregnancy may be the result of different processes;
- • Other untreated sleep disorders (e.g., sleep apnea, periodic limb movement disorder), assessed by clinical interview. Participants meeting criteria for a sleep disorder requiring intervention will be referred for care through the local Medical Centers or their preferred sleep disorders center.
About Idaho State University
Idaho State University (ISU) is a leading academic institution dedicated to advancing health sciences through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, ISU leverages its extensive resources and expertise to conduct rigorous clinical studies that contribute to the understanding and treatment of various medical conditions. The university is committed to ethical research practices and the highest standards of scientific integrity, aiming to translate findings into meaningful improvements in patient care and public health. Through its clinical trial initiatives, ISU actively engages with the community and fosters partnerships that enhance academic knowledge and promote health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pocatello, Idaho, United States
Patients applied
Trial Officials
Sarah Emert
Principal Investigator
Idaho State University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported